Lawrence Otto Klein - Net Worth and Insider Trading
Lawrence Otto Klein Net Worth
The estimated net worth of Lawrence Otto Klein is at least $53,267 dollars as of 2024-11-13. Lawrence Otto Klein is the CBO & COO of CRISPR Therapeutics AG and owns about 1,050 shares of CRISPR Therapeutics AG (CRSP) stock worth over $53,267. Details can be seen in Lawrence Otto Klein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lawrence Otto Klein has not made any transactions after 2021-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lawrence Otto Klein
Lawrence Otto Klein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lawrence Otto Klein owns 3 companies in total, including CRISPR Therapeutics AG (CRSP) , Dyne Therapeutics Inc (DYN) , and Jasper Therapeutics Inc (JSPR) .
Click here to see the complete history of Lawrence Otto Klein’s form 4 insider trades.
Insider Ownership Summary of Lawrence Otto Klein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2021-03-23 | Chief Business Officer |
| DYN | Dyne Therapeutics Inc | 2020-09-16 | director |
| JSPR | Jasper Therapeutics Inc | 2021-09-24 | director |
Lawrence Otto Klein Latest Holdings Summary
Lawrence Otto Klein currently owns a total of 1 stock. Lawrence Otto Klein owns 1,050 shares of CRISPR Therapeutics AG (CRSP) as of March 23, 2021, with a value of $53,267.
Latest Holdings of Lawrence Otto Klein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2021-03-23 | 1,050 | 50.73 | 53,267 |
Holding Weightings of Lawrence Otto Klein
Lawrence Otto Klein Form 4 Trading Tracker
According to the SEC Form 4 filings, Lawrence Otto Klein has made a total of 4 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 100,000 shares on March 23, 2021, which brought Lawrence Otto Klein around $13 Million.
Insider Trading History of Lawrence Otto Klein
- 1
Lawrence Otto Klein Trading Performance
Lawrence Otto Klein Ownership Network
Ownership Network List of Lawrence Otto Klein
Ownership Network Relation of Lawrence Otto Klein
Lawrence Otto Klein Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Lawrence Otto Klein is the Chief Business Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , General Counsel and Secretary James R. Kasinger , and Chief Financial Officer Raju Prasad .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Lawrence Otto Klein made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 179,630 shares made by Samarth Kulkarni , a net sale of 6,949 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 5,382 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 5,382 shares. During the past 18 months, 193,469 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 193,469 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Lawrence Otto Klein Mailing Address
Above is the net worth, insider trading, and ownership report for Lawrence Otto Klein. You might contact Lawrence Otto Klein via mailing address: C/o Crispr Therapeutics Ag, 610 Main Street 7th Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
